Niagen Bioscience Inc (NAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,925 | -13,828 | -9,613 | -5,902 | -32,147 |
| Depreciation Amortization | 1,114 | 834 | 554 | 276 | 1,854 |
| Accounts receivable | -555 | 1,698 | 952 | 1,326 | -44 |
| Accounts payable and accrued liabilities | -181 | -2,745 | 154 | -1,467 | 78 |
| Other Working Capital | 347 | -408 | 1,190 | 1,125 | -202 |
| Other Operating Activity | 8,600 | 3,827 | -14 | -579 | 10,022 |
| Operating Cash Flow | $-10,600 | $-10,622 | $-6,777 | $-5,221 | $-20,439 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -124 | -147 | -107 | -15 | -190 |
| Purchase Sale Intangibles | -18 | -18 | N/A | N/A | -10 |
| Other Investing Activity | -41 | -34 | -15 | -5 | -59 |
| Investing Cash Flow | $-165 | $-181 | $-122 | $-20 | $-249 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 10,000 |
| Common Stock Issued | 8,971 | 7,715 | 7,168 | 132 | 7,838 |
| Other Financing Activity | -321 | -246 | -191 | -95 | -954 |
| Financing Cash Flow | $8,650 | $7,469 | $6,977 | $37 | $16,884 |
| Beginning Cash Position | 18,812 | 18,812 | 18,812 | 18,812 | 22,616 |
| End Cash Position | 16,697 | 15,478 | 18,890 | 13,608 | 18,812 |
| Net Cash Flow | $-2,115 | $-3,334 | $78 | $-5,204 | $-3,804 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,600 | -10,622 | -6,777 | -5,221 | -20,439 |
| Capital Expenditure | -124 | -147 | -107 | -15 | -743 |
| Free Cash Flow | -10,724 | -10,769 | -6,884 | -5,236 | -21,182 |